Dr. Fan Lin

Fan Lin, MD, PhDFAN LIN, MD PhD
Division Director of Anatomic Professional Services and Development

100 North Academy Avenue
Danville, PA 17822-1920
1 800 695 6491

Dr. Lin is the Director of Anatomic Pathology for Geisinger Medical Laboratories, where he serves as the Division Director of Anatomic Pathology Professional Services and Development.

Education:

Dr. Lin obtained his M.D. from Fujian Medical University, Fuzhou, in the People's Republic of China. He completed his residency in anatomic pathology at the University of Chicago Hospitals, Chicago, Illinois, and a fellowship in cytopathology at the University of Texas, M.D. Anderson Cancer Center, in Houston, Texas.

Certifications:

He is board certified in anatomic, clinical and cytopathology Dr. Lin's areas of specialization are renal pathology, cervical gynecologic pathology, gastrointestinal , genitourinary pathology , liver pathology, thyroid pathology and cytopathology.

Professional Affiliations:

College of American Pathologists
United States and Canadian Academy of Pathology
American Society of Cytopathology
PA Pathology Society

Research Interests:

Renal pathology

Publications in Peer-Reviewed Journals:

Liu H, Shi J, Lin F. The potential diagnostic utility of TROP-2 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2017; 25(8):525-533 .

Kandukuri S, Lin F, Liu H. Application of IHC on FNA and small tissue biopsy specimens. Arch Pathol Lab Med. 2017; In:Press .

Wang HL, Lin F. Application of IHC on GI, liver, pancreas and biliary tract. Arch Pathol Lab Med. 2017; In :preparation .

Lin F, Shi J, Ma X, et al. Detection of albumin expression by RNA in situ hybridization in hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Am J Clin Pathol. 2017; In :preparation .

Liu H, Shi J, Ma X, Lin F, et al. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of GCDFP15 in breast carcinomas. Am J Clin Pathol. 2017; In :preparation .

Shahab A, Liu H, Lin F. . Uroplakin II is a Useful Immunomarker for Identification of Urothelial Carcinomas. Am J Clin Pathol. 2017; In :preparation .

Kandukuri S, Liu H, Lin F. The diagnostic utility of CK7, maspin and MUC5AC in distinguishing gastric-foveolar type mucinous neoplasm of the pancreas from gastric contaminants on fine needle aspiration specimens. Am J Clin Pathol. 2017; In :preparation .

Wang HL, Kim CJ, Koo J, Zhou W, Choi EK, Arcega R, Chen ZE, Wang H, Zhang L, Lin F. Practical immunohistochemistry in neoplastic pathology of the gastrointestinal tract, liver, biliary tract, and pancreas. Arch Pathol Lab Med. 2017; 141:155-1180 .

Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, Lin F. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Arch Pathol Lab Med. 2016; 140(4):332-349 .

Kim CJ, Baruch-Oren T, Lin F, Fan XS, Yang XJ, Wang HL. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas. J Clin Pathol. 2016; 69(12):1046-1050 .

Chen L, Huang K, Himmelfarb EA, Zhai J, Lai JP, Lin F, Wang HL. Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy. Hum Pathol. 2015; 46(11):1647-1654 .

Chen ZM, Lin F. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.. Arch Pathol Lab Med. 2015; 139(1):14-23 .

Liu H, Lin F. Application of immunohistochemistry in thyroid pathology. Arch Pathol Lab Med. 2015; 139(1):67-82 .

Lin F, Chen ZM, Wang HL. Utility of immunohistochemistry in the pancreatobiliary tract.. Arch Pathol Lab Med. 2015; 139(1):24-38 .

Wilkerson M, Liu H, Lin F, Cheng L. Genitourinary System (Urinary Bladder, Testis, Prostate and Kidney). Review article. Arch Pathol Lab Med. 2014; 138(12):1643-1665 .

Lin F, Chen Z. Standardization of diagnostic immunohistochemistry: literature review and geisinger experience. Arch Pathol Lab Med. 2014; 138(2):1564-1577 .

Luong-Player A, Liu H, Wang HL, Lin F. Immunohistochemical re-evaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues. Am J Clin Pathol. 2014; 141:219-225 .

Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol. 2014; 46(2):379-88 .

Lai JP, Chen ZM, Lok T, Chan OT, Himmelfarb E, Zhai Q, Lin F, Wang HL. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions. J Clin Pathol. 2014; 67(6):464-469 .

Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, Wang HL, Liu H. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014; 138:1015-1026 .

Lok T. Chen L, Lin F, Wang HL. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Hum Pathol. 2014; 45:394-400 .

Liu H, Shi J, Prichard JW, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol. 2014; 141:648-655 .

Shieh FK, Luong-Player A, Khara HS, Liu H, Lin F, Shellenberger MJ, Johal AS, Diehl DL. Improved endoscopic retrograde cholangiopancreatography brush increases diagnostic yield of malignant biliary strictures. World J Gastrointest Endosc. 2014; 6(7):266-333 .

Lin F, Liu H. Iimmunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. . Arch Pathol Lab Med. 2014; 138(12):1583-1610 .

Lin F. Evolving practices of diagnostic immunohistochemistry. Arch Pathol Lab Med. 2014; 138(12):1561-1563 .

Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med. 2014; 138(12):1643-1655 .

Shi J, Liu H, Wang HL, Prichard JW, Lin F. Diagnostic utility of von Hippel-Lindau gene product, maspin IMP3, and S100P in adenocarcinoma of the gallbladder. Hum Pathol. 2013; 44(4):503-511 .

Liu H, Shi J, Wilkerson M, Yang XJ, Lin F. Immunohistochemical evaluation of ERG expression in various benign and malignant tissues. Ann Clin Lab Sci. 2013; 43:3-9 .

Shi J, Liu H, Wang HL, Prichard JW, Lin F. Diagnostic utility of pVHL, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder. Hum Pathol. 2013; 44:503-511 .

Abstracts, Posters, and Other Presentations:

Lin F. The Third CAPA-China Pathology meeting. Organizer. CAPA, San Antonio, Texas, March 4, 2017.

Lin F, et al. Detection of albumin expression by RNA in situ hybridization is a sensitive and specific method for identification of hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Piazza Y, Liu H, Lin F. Immunohistochemical Detection of Loss Expression of ATRX/DAXX in Neuroendocrine Tumors from Various Organs. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Swarrow RS, Liu H, Lin F. Diagnostic Utility of VHL, Maspin, IMP3 and S100P in the Evaluation of Pancreatic Resection Margins from Frozen Tissue. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Piazza Y, Lin F, Liu H. The Correlation of Afirma® Gene Expression Classifier Results with Follow-Up Findings for Thyroid Fine Needle Aspiration Specimens. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Swarrow RS, Lin F, Liu H. Analysis of the atypia of undetermined significance/follicular lesion of undetermined significant (AUS/FLUS) category – experience from a large health system. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Chen ZE, Bitting A, Lin F. Assessment of PD-L1 expression in tumor microenvironment of mismatch repair deficient colon cancer: comparing two antibody clones, SP142 vs. SP263. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Zhang S, Liu F, Shi J, Chi P, Lin F, Stellino A, Shen H, Wang HL. Diagnostic Value of Clusterin Immunostaining in Hepatocellular Carcinoma: A Comparison with pCEA and CD10. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Liu H, Wilkerson M, Lin F. NKX3.1 is the Most Sensitive Immunohistochemical Marker in Identifying Metastatic Prostatic Carcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Liu H, Wilkerson M, Lin F. Immunohistochemical Evaluation of NKX3.1 Expression in Prostatic Ductal Adenocarcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Lin F. The Second CAPA Diagnostic Pathology Course . Organizer. CAPA, Houston, Texas, November 12, 2016.

Lin F. The First Geisinger Annual Pathology Seminar. Course Director. Pathology Seminar, Geisinger Medical Center, September 16-18, 2016.

Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First Geisinger Annual Pathology Seminar , Geisinger Medical Center, September 16, 2016.

Lin F. Chinese American Pathologists Association Companion meeting. Organizer. Chinese American Pathologists Association Companion meeting at the CAP 2016 annual meeting , Las Vegas, Nevada, September 24, 2016.

Liu H, Shi J, Lin F. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of GCDFP15 expression in breast carcinomas. . Poster presentation. College of American Pathologists, September 24-28, 2016, Las Vegas, Nevada.

Hu L, Liu H, Lin F. Re-evaluation and Identification of the Most Effective Immunohistochemical Panel in Distinguishing Papillary Renal Cell Carcinoma from Papillary Urothelial Carcinoma. Poster Presentation. College of American Pathologists, Las Vegas, Nevada, September 24-28, 2016.

Lin F. Updates on new antibodies on FNA and small tissue biopsies. Presentation. The Association of Chinese American Physicians, New York, New York, May 22, 2016.

Chen ZE, Bitting A, Kip NS, Lin F. Quality Assurance Aspects of implementing BRAFV600E Immunohistochemistry (IHC) Assay in Universal Lynch Syndrome Screening (ULS) for Colorectal Cancer (CRC): A Single Institution Experience. Abstract. United States and Canadian Academy of Pathology, March 12-16, 2016, Seattle, Washington.

Chen Z, Li H, Kip NS, Lin F. Detection of mismatch repair protein (mmr) loss by immunohistochemistry (IHC) in colorectal adenomas from young patients: an appraisal of its utility in lynch syndrome screening. Abstract/Presentation. USCAP Annual Meeting, Seattle, WA, March 2016.

Zhou W, Koo J, Wang HL, Liu H, Chen Z, Lin F. Diagnostic utility of clusterin immunostaining in differentiating hepatocellular carcinoma from tumors of other origins. Abstract/Presentation. USCAP Annual Meeting, Seattle, WA, March 2016.

Kandukuri S, Liu H, Lin F. The diagnostic utility of CK7, maspin and MUC5AC in distinguishing gastric-foveolar type mucinous neoplasm of the pancreas from gastric contaminants on fine needle aspiration specimens. Platform Presentation. USCAP Annual Meeting, Seattle, WA, March 12-18, 2016.

Liu H, Song QZ, Zhang Y, Chang Z, Lin F. Optimization of rapid immunohistochemical stains on frozen tissue sections. Poster. USCAP Annual Meeting, Seattle, WA, March 12-18, 2016.

Liu H, Shi J, Xu V, Lin F. Impact of tissue decalcification on immunohistochemical detection of germ cell tumor markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

Shi J, Xu V, Liu H, Lin F. Impact of tissue decalcification on immunohistochemical detection of lymphoid markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

Lin F, Shi J , Xu V, Liu H. Impact of tissue decalcification on immunohistochemical detection of melanoma markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

Deng HB, Gao H, Zhang X, Lin F, Godyn J. E-Cadherin as a Potential Marker for Differential Diagnosis of Goblet Cell Carcinoid and Signet Ring Cell Carcinoma in Vermiform Appendix:. Poster 79. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2015.

Lin F. Impact of Tissue Decalcification on Immunohistochemical Detection of Lymphoid Markers. Poster 68. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2015.

Lin F. Diagnostic Pathology Symposium. Co-Organizer. CAPA-Beijing , Beijing, China, October 16-18, 2015.

Lin F. Select topics on pancreatobiliary pathology- IHC approach. Presented by Dr. H. Liu. CAPA-Beijing , Beijing, China, October 17, 2015.

Lin F. Select topics on pancreatobiliary pathology- IHC approach. Lecture. China Cancer Hospital, Bejing, China, October 17, 2015.

Lin F. Diagnostic Pathology Course. Course Director. Chinese American Pathologists Association (CAPA), Flushing, NY, August 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First Chinese American Pathologists Association (CAPA) Diagnostic Pathology Course, Flushing, NY, August 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Boston University, Boston, MA, August 2015.

Lin F. The First Chinese American Pathologists Association (CAPA) . Diagnostic Pathology Course. CAPA, Flushing, New York, August 22-24, 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First CAPA Diagnostic Pathology Course, Flushing, New York, August 22, 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Boston University, Boston, Massachusetts, August 28, 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Temple University Hospital, Philadelphia, Pennsylvalnia, May 22, 2015.

Lin F. IHC Quality Management. Pathology Grand Rounds. Temple University Hospital, Philadelphia, Pennsylvalnia, May 22, 2015.

Lin F. Undifferentiated carcinoma: using IHC approach; IHC quality management. Grand Rounds. Temple University Hospital, Philadelphia, PA, May 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Methodist Hospital, Houston, Texas, April 7, 2015.

Lin F. Undifferentiated carcinoma: using IHC approach. Grand Rounds. Methodist Hospital, Houston, TX, April 2015.

Liu H, Lin F. Immunohistochemical expression of NKX2.2 in 1228 human tumors. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

Liu H, Lin F. Immunohistochemical expression of NKX3.1 in human tumors. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

Lin F, Shi J, Chen Z, Liu H. Impact of tissue decalcification on immunohistochemical detection of select markers for carcinoma of unknown origin. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

Shi J, Xu V, Liu H, Lin F. Impact of tissue decalcification on immunohistochemical detection of breast carcinoma markers. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

Chen Z, Yin H, Li J, Zhu S, Lin F. Improving HER2 assessment in gastroesophageal junction (GEJ) and gastric adenocarcinoma (GADC): lessons from concurrent immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) study of 117 specimens. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

Liu H, Shi J, Xu V, Lin F. Impact of tissue decalcification on immunohistochemical detection of select sarcoma markers. Poster. USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

Lin F, Shi J , Xu V, Liu H. Impact of Tissue Decalcification on Immunohistochemical Detection of Melanoma Markers. Poster Presentation. The United States and Canadian Academy of Pathology, Boston, Massachusetts, March 21-27, 2015.

Wilkinson L, Liu H, Meschter S, Aaron K, Lin F. Effect of Needle Rinse Solution on Cellularity of Cellblock Preparations in Fine Needle Aspiration Biopsies. Poster Presentation. United States and Canadian Academy of Pathology, Boston, Massachusetts, March 2015.

Lin F. Geisinger Pathology Lecture Series. Lecture organizer. Geisinger Pathology Lecture Series, Geisinger Medical Center, Danville PA, Throughout 205.

Lin F, Shahab A, Liu H. Diagnostic utility of cell blocks with immunostains in Papanicolaou tests (liquid-based preparation). Presentation. ASC Annual Meeting, Dallas, TX, November 1-17, 2014.

Lin F, Shi J, Chen ZM, Liu H. Immunohistochemical evaluation of c-Myc expression in carcinomas from various organs. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

Liu H, Okponobi S, Shi J, Lin F. Identification of a useful immunostaining panel in the distinction between esophageal and pancreatic adenocarcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

Liu H, Lin F. Re-evaluation of expression of immunomarkers in lung adenocarcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

Liu H, Lin F. Immunohistochemical evaluation of Ber-EP4, MOC-31, TAG-72, and CEA in various carcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

Mi W, Diehl Dl, Shi J, Blansfield J, Hunsinger MA, Yang W, Lin F. S100P is a potential biomarker in distinguishing mucinous from non-mucinous pancreatic cysts and predicting invasive adenocarcinoma. Presentation. AACR Annual Meeting, San Diego, CA, April 5-9, 2014.

Shahab A, Liu H, Lin F. Uroplakin II is a useful immunomarker for identification of urothelial carcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

Lin F, Shi J, Liu H. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of napsin A expression in lung adenocarcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

Liu H, Shi J, Prichard J, Lin F. TROP-2 is a potential novel immunomarker for identification of papillary thyroid carcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

Chen ZM, Liu H, Lin F. Loss of PAX2 nuclear expression: a useful diagnostic feature for in situ and invasive endocervical adenocarcinoma. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

Luong-Player A, Liu H, Wang HL, Lin F. Immunohistochemical re-evaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues. Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Meng X, Liu H, Lin F. Immunohistochemical evaluation of hepatocyte nuclear factor 1B (HNF-1B) expression in tumors from various organs. Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Meng X, Lin F, Liu H. Analysis of the atypia of undetermined significance/follicular lesion of undetermined significant (AUS/FLUS) category – experience from 1,366 thyroid fine needle aspiration biopsy (FNA) cases. Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Zhu S, Lin F, Chen ZM, . Low frequency of HER2 overexpression and amplification detected by immunohistochemical stain and dual chromogenic in situ hybridization (CISH) in pancreatic ductal adenocarcinoma. Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Chen ZM, Zhu S, Liu H, Lin F. Loss expression of CDX2 and CK20 in medullary carcinoma of the colon is associated with poor survival. Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Chen ZM, Lin X, Wang M, Lin F, Rao S. Regenerative nodule-like intrahepatic cholangiocarcinoma: is it a morphology for in situ cholangioarcinoma arising in cirrhotic liver? . Presentation. CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Lin F, Luong-Player A, Diehl D, Liu H. Parameters Impacting the Diagnostic Sensitivity of Biliary Brush Cytology. Poster presentation. College of American Pathologists, Orlando, Florida, October 2013.

Johnson B, Khalil M, Blansfield J, Lin F, Zhu S, Kirchner HL. Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma. Presentation. ASCO Annual Meeting, San Francisco, CA, May 2013.

Shieh FK, Luong-Player A, Liu H, Lin F, Shellenberger M, Inverso N, Johal AS, Diehl D. Improved ERCP cytology brush design and standardized specimen handling yields more tissue and gives higher diagnostic sensitivity in the diagnosis of malignant biliary strictures. Presentation. ASCO Annual Meeting, San Francisco, CA, May 2013.

Liu H, Shi J, Prichard J, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Platform presentation. USCAP Annual Meeting, Baltimore, MD, March 2-8-2013.

Liu H, Shi J, Prichard JW, Yun G, Lin F. Immunohistochemical evaluation of TFF1 and TFF3 expression in ER-negative breast carcinomas. Platform Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Lin F, Shi J, Aihua L, Chen T, Liu H. Stathmin expression in tumors from various organs - a useful biomarker for confirming endocervical adenocarcinoma and cervical squamous intraepithelial lesions. Poster Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Yang XJ, Dykema K, Villa C, Jia L, Lin F, Shen S, Teh B. Is papillary renal cell carcinoma derived from proximal convoluted tubules?. Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Lin F, Shi J, Wilkerson M, Liu H. SALL4 and PAX8 expression in carcinomas from various organs. Poster Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Liu H, Shi J, Lin F. TROP2 expression in various tumors – a potential diagnostic marker for papillary thyroid carcinoma. Poster Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Zhu S, Lin F, Chen ZM. Mitosis-specific marker PHH3 immunostain is a more sensitive and efficient method to evaluate the mitotic activity in gastrointestinal stromal tumor (GIST). Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Wilkerson M, Lin F, Shi J. SF-1 immunohistochemical expression in tumors. Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Deng H, Shi J, Lin F. The utility of GLUT-1, CD146 and KOC immunostains in distinguishing malignant mesothelioma and reactive mesothelial cells from pleural effusion. Abstract 356. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Wilkerson M, Lin F, Shi J. SF-1 immunohistochemical expression in tumors. Abstract. United States and Canadian Academy of Pathology, Baltimore, Maryland, March 2-8, 2013.

Textbook Chapters

Lin F, Liu H. Unknown primary/undifferentiated neoplasms in surgical and cytologic specimens. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 119-164.

Liu H, Wilkerson M, Lin F. Thyroid, parathyroid, and adrenal gland. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 285-286.

Lin F, Yang X. Kidney. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 439-464.

Li JH, Lin F. Upper gastrointestinal tract. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 535-542.

Chen ZM, LI J, Lin F. Lower gastrointestinal tract. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 543-556.

Chen ZM, Prichard J, Lin F. Liver, Bile Ducts and Gallbladder. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 503-524.

Lin F, Wang HL. Pancreas and ampullae. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 481-502.

Chen ZM, Lin F. Overview of Predictive Biomarkers and Integration of IHC into Molecular Pathology. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 91-104.

Lin F, Prichard J, Bitting AK, et al.. Geisinger Immunohistochemical Antibodies and Staining Protocols. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 39-56.

Lin F, Shi J. Standardization of diagnostic immunohistochemisry. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Springer, New York, 2015, 17-30.

Lin F, Prichard J, Bitting A, Shi J, Liu H, Wilkerson M, Chen Z. Geisinger immunohistochemical antibodies and staining protocols. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. 2nd ed.. Lin F, Prichard JW, Liu H, Wilkeson M, Chen ZM, eds. Springer, New York, 2015, 39-56.

Liu H, Lin F, QiHui Z. Prostate Gland. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. 2nd edition. Lin F, Prichard JW, Liu H, Wilkeson M, Chen ZM, eds. Springer, New York, 2015, 397-420.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2019 Geisinger Health System.   All rights reserved.